Pharmaceutical industry groups are urging the US Food and Drug Administration to refine its draft guidance on ...
EMMA International helps regulatory organizations design and implement structured submission planning approaches ...
The US Food and Drug Administration has updated two key guidance documents that significantly ease regulatory ...
The International Medical Device Regulators Forum (IMDRF) has released a new strategic plan outlining its ...
Radicava holds a unique position in the ALS treatment landscape. The intravenous formulation received FDA approval ...
Regulatory inspections are no longer isolated events tied to a single submission or approval milestone. Across ...
The European Commission’s Medical Device Coordination Group (MDCG) has issued new guidance clarifying how medical ...
Infant botulism occurs when spores of C. botulinum are ingested and produce toxins in an infant’s immature ...
As therapies become more complex, early regulatory engagement is no longer a best practice but a necessity. Cell ...
EMMA International announced the launch of its AI Solutions. This new offering is designed to help regulated ...
Regulatory intelligence goes beyond tracking new guidance. It involves systematically analyzing regulatory ...
US Food and Drug Administration has proactively added Janssen Pharmaceuticals’ combination therapy of teclistamab ...